5 - FU

DRUG2 trials

Sponsors

Eli Lilly and Company, Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.

Conditions

Esophageal Squamous Cell CarcinomaSolid Tumor

Phase 2

A Study in Advanced Solid Tumors

CompletedNCT01063075

Eli Lilly and CompanySolid Tumor

Start: 2010-06-30End: 2015-10-31Updated: 2019-09-26

SKB500 Combinations in Patients With Esophageal Squamous Cell Carcinoma

RecruitingNCT07700667

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.Esophageal Squamous Cell Carcinoma

Start: 2026-08-13End: 2029-12-31Target: 120Updated: 2026-08-26